Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Busin...(September 30 September 30 ...),Health

2007 2006 2007 2006

REVENUE:

PCT products, services,

other $106,787 $92,211 $281,084 $174,409

Grant revenue 31,26 - 190,715 -

Total revenue 138,052 92,211 471,799 174,409

COSTS AND EXPENSES:

Cost of PCT products and

services 42,276 90,037 131,558 188,688

Research and development 519,303 324,525 1,518,851 984,844

Selling and marketing 379,448 127,419 986,801 322,803

General and administrative 578,238 380,065 1,683,782 1,665,172

Total operating costs and

expenses 1,519,265 922,046 4,320,992 3,161,507

Operating loss from

continuing operations (1,381,213) (829,835) (3,849,193) (2,987,098)

OTHER INCOME:

Realized gain on securities

available for sale - - 2,028,720 517,938

Interest income 75,732 88,190 227,816 305,982

Total other income 75,732 88,190 2,256,536 823,920

Loss from continuing

operations before income

taxes (1,305,481) (741,645) (1,592,657) (2,163,178)

Income tax benefit from

continuing operations 209,503 111,106 253,539 408,344

Loss from continuing

operations (1,095,978) (630,539) (1,339,118) (1,754,834)

DISCONTINUED OPERATIONS:

Gain on sale of net assets

related to discontinued

operations (net of income

tax of $218,060) - - 1,155,973 -

Net loss $(1,095,978) $(630,539) $(183,145)$(1,
'/>"/>